Engineers Gate Manager’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$593K Buy
9,270
+3,810
+70% +$264K 0.01% 1315
2025
Q4
$434K Buy
+5,460
New +$461K 0.01% 1434
2025
Q2
Sell
-16,810
Closed -$834K 2346
2025
Q1
$834K Buy
16,810
+3,959
+31% +$220K 0.01% 1167
2024
Q4
$815K Buy
+12,851
New +$743K 0.01% 1129
2024
Q2
Sell
-4,560
Closed -$284K 2080
2024
Q1
$284K Sell
4,560
-6,867
-60% -$445K 0.01% 1489
2023
Q4
$660K Buy
+11,427
New +$585K 0.02% 1032
2022
Q1
Sell
-334
Closed -$29K 2074
2021
Q4
$29K Buy
+334
New +$32.7K ﹤0.01% 1917

Other funds holding IRON

Engineers Gate Manager's IRON Position: Q1 2026 in Review

Engineers Gate Manager increased its Disc Medicine (IRON) stake by 70% in Q1 2026, buying an estimated $264K and bringing the position to 9,270 shares worth $593K. The position accounts for 0.01% of the portfolio, ranked #1315.

Engineers Gate Manager first reported a position in IRON in Q4 2021 and has held it in 7 quarters since. The position peaked at $834K in Q1 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Engineers Gate Manager held 9,270 shares of Disc Medicine worth $593K as of Q1 2026.
  • Engineers Gate Manager bought 3,810 Disc Medicine shares in Q1 2026, an estimated $264K.
  • Disc Medicine made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1315 holding.
  • Engineers Gate Manager first reported a position in Disc Medicine in Q4 2021 and has held it in 7 quarters since.
  • Engineers Gate Manager's Disc Medicine position peaked at $834K in Q1 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.